Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2016-12

AUTHORS

H. J. Gray, B. Benigno, J. Berek, J. Chang, J. Mason, L. Mileshkin, P. Mitchell, M. Moradi, F. O. Recio, C. M. Michener, A. Alvarez Secord, N E. Tchabo, J. K. Chan, J. Young, H. Kohrt, S. E. Gargosky, J. C. Goh

ABSTRACT

BACKGROUND: CAN-003 was a randomized, open-label, Phase 2 trial evaluating the safety, efficacy and immune outcomes of CVac, a mucin 1 targeted-dendritic cell (DC) treatment as a maintenance therapy to patients with epithelial ovarian cancer (EOC). METHODS: Patients (n = 56) in first (CR1) or second clinical remission (CR2) were randomized (1:1) to standard of care (SOC) observation or CVac maintenance treatment. Ten doses were administered over 56 weeks. Both groups were followed for progression-free survival (PFS) and overall survival (OS). RESULTS: Fifty-six patients were randomized: 27 to SOC and 29 to CVac. Therapy was safe with only seven patients with Grade 3-4 treatment-emergent adverse events. A variable but measurable mucin 1 T cell-specific response was induced in all CVac-treated and some standard of care (SOC) patients. Progression free survival (PFS) was not significantly longer in the treated group compared to SOC group (13 vs. 9 months, p = 0.36, hazard ratio [HR] = 0.73). Analysis by remission status showed in the CR1 subgroup a median PFS of 18 months (SOC) vs. 13 months (CVac); p = 0.69 (HR = 1.18; CI 0.52-2.71). However CR2 patients showed a longer median PFS in the CVac-treated group (median PFS not yet reached, >13 vs. 5 months; p = 0.04, HR = 0.32 CI). OS for CR2 patients at 42 months of follow-up showed a difference of 26 months for SOC vs. > 42 months for CVac-treated (as median OS had not been reached; HR = 0.17 (CI 0.02-1.4) with a p = 0.07). CONCLUSIONS: CVac, a mucin 1-dendritic cell maintenance treatment was safe and well tolerated in ovarian cancer patients. A variable but observed CVac-derived, mucin 1-specific T cell response was measured. Notably, CR2 patients showed an improved PFS and lengthened OS. Further studies in CR2 ovarian cancer patients are warranted (NCT01068509). TRIAL REGISTRATION: NCT01068509. Study Initiation Date (first patient screened): 20 July 2010. Study Completion Date (last patient observation): 20 August 2013, the last patient observation for progression-free survival; 29 April 2015, the last patient was documented regarding overall survival. More... »

PAGES

34

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x

DOI

http://dx.doi.org/10.1186/s40425-016-0137-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1033181369

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/27330807


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Washington Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412623.0", 
          "name": [
            "University of Washington Medical Center, Seattle, WA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gray", 
        "givenName": "H. J.", 
        "id": "sg:person.0735642527.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735642527.91"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Northside Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416555.6", 
          "name": [
            "Northside Hospital, Atlanta, GA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benigno", 
        "givenName": "B.", 
        "id": "sg:person.01301461705.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301461705.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Stanford Women\u2019s Cancer Center, Stanford, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Berek", 
        "givenName": "J.", 
        "id": "sg:person.010516421017.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010516421017.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Marin Cancer Care, Greenbrae, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chang", 
        "givenName": "J.", 
        "id": "sg:person.014767761117.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014767761117.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Scripps Health", 
          "id": "https://www.grid.ac/institutes/grid.419722.b", 
          "name": [
            "Scripps Cancer Center, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mason", 
        "givenName": "J.", 
        "id": "sg:person.012011361041.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012011361041.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Peter MacCallum Cancer Centre", 
          "id": "https://www.grid.ac/institutes/grid.1055.1", 
          "name": [
            "Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mileshkin", 
        "givenName": "L.", 
        "id": "sg:person.01306256505.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306256505.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Austin Health", 
          "id": "https://www.grid.ac/institutes/grid.410678.c", 
          "name": [
            "Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mitchell", 
        "givenName": "P.", 
        "id": "sg:person.01240411533.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240411533.17"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Lower Manhattan Hospital", 
          "id": "https://www.grid.ac/institutes/grid.416112.1", 
          "name": [
            "New York Downtown Hospital, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moradi", 
        "givenName": "M.", 
        "id": "sg:person.014201702441.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014201702441.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "South Florida Center for Gynecologic Oncology, Boca Raton, FL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Recio", 
        "givenName": "F. O.", 
        "id": "sg:person.0766200410.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766200410.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cleveland Clinic", 
          "id": "https://www.grid.ac/institutes/grid.239578.2", 
          "name": [
            "Cleveland Clinic Foundation, Cleveland, OH, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Michener", 
        "givenName": "C. M.", 
        "id": "sg:person.01240016453.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240016453.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Duke University", 
          "id": "https://www.grid.ac/institutes/grid.26009.3d", 
          "name": [
            "Duke Cancer Institute, Duke University Health System, Durham, NC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Secord", 
        "givenName": "A. Alvarez", 
        "id": "sg:person.01153251200.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153251200.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Morristown Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.416113.0", 
          "name": [
            "Morristown Medical Center, Morristown, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tchabo", 
        "givenName": "N E.", 
        "id": "sg:person.01206754423.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206754423.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, San Francisco", 
          "id": "https://www.grid.ac/institutes/grid.266102.1", 
          "name": [
            "University of California, San Francisco & Sutter Health Research Institute, San Francisco, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chan", 
        "givenName": "J. K.", 
        "id": "sg:person.013072753512.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013072753512.00"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical University of South Carolina", 
          "id": "https://www.grid.ac/institutes/grid.259828.c", 
          "name": [
            "Medical University of South Carolina, Charleston, SC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Young", 
        "givenName": "J.", 
        "id": "sg:person.011262113641.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011262113641.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Stanford University", 
          "id": "https://www.grid.ac/institutes/grid.168010.e", 
          "name": [
            "Stanford University Cancer Institute, Stanford, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kohrt", 
        "givenName": "H.", 
        "id": "sg:person.01144535603.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144535603.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Prima BioMed, Sydney, NSW, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gargosky", 
        "givenName": "S. E.", 
        "id": "sg:person.01116001617.09", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116001617.09"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Greenslopes Private Hospital, Royal Brisbane & Women\u2019s Hospital, University of Queensland & Gallipoli Research Foundation, Greenslopes, QLD, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Goh", 
        "givenName": "J. C.", 
        "id": "sg:person.013452435241.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013452435241.07"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1056/nejmoa1507643", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000663586"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2051-1426-2-16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007070580", 
          "https://doi.org/10.1186/2051-1426-2-16"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2051-1426-2-16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007070580", 
          "https://doi.org/10.1186/2051-1426-2-16"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ygyno.2007.02.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009417955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-05-1574", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009558049"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1021/jm5018237", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010331914"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jcyt.2013.01.184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014256254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/2051-1426-1-s1-p213", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018712024", 
          "https://doi.org/10.1186/2051-1426-1-s1-p213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1510665", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019970557"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2006.09.4540", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020656211"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1309/9r6673qec06d86y4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021159180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2008.10.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026558254"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/imt.10.17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032207164"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1104390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035779003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1104390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035779003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/92.18.1534", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038214940"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2217/fon.14.313", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038967503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.55.7348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051247162"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1103799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052109861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1103799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052109861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1504627", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052572745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00018-015-2014-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053537243", 
          "https://doi.org/10.1007/s00018-015-2014-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14712598.2015.1088519", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1067589143"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1615/critrevimmunol.v14.i3-4.40", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068131598"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-12", 
    "datePublishedReg": "2016-12-01", 
    "description": "BACKGROUND: CAN-003 was a randomized, open-label, Phase 2 trial evaluating the safety, efficacy and immune outcomes of CVac, a mucin 1 targeted-dendritic cell (DC) treatment as a maintenance therapy to patients with epithelial ovarian cancer (EOC).\nMETHODS: Patients (n\u2009=\u200956) in first (CR1) or second clinical remission (CR2) were randomized (1:1) to standard of care (SOC) observation or CVac maintenance treatment. Ten doses were administered over 56\u00a0weeks. Both groups were followed for progression-free survival (PFS) and overall survival (OS).\nRESULTS: Fifty-six patients were randomized: 27 to SOC and 29 to CVac. Therapy was safe with only seven patients with Grade 3-4 treatment-emergent adverse events. A variable but measurable mucin 1\u00a0T cell-specific response was induced in all CVac-treated and some standard of care (SOC) patients. Progression free survival (PFS) was not significantly longer in the treated group compared to SOC group (13 vs. 9\u00a0months, p\u2009=\u20090.36, hazard ratio [HR]\u2009=\u20090.73). Analysis by remission status showed in the CR1 subgroup a median PFS of 18\u00a0months (SOC) vs. 13\u00a0months (CVac); p\u2009=\u20090.69 (HR\u2009=\u20091.18; CI 0.52-2.71). However CR2 patients showed a longer median PFS in the CVac-treated group (median PFS not yet reached, >13 vs. 5\u00a0months; p\u2009=\u20090.04, HR\u2009=\u20090.32 CI). OS for CR2 patients at 42\u00a0months of follow-up showed a difference of 26\u00a0months for SOC vs. > 42\u00a0months for CVac-treated (as median OS had not been reached; HR\u2009=\u20090.17 (CI 0.02-1.4) with a p\u2009=\u20090.07).\nCONCLUSIONS: CVac, a mucin 1-dendritic cell maintenance treatment was safe and well tolerated in ovarian cancer patients. A variable but observed CVac-derived, mucin 1-specific T cell response was measured. Notably, CR2 patients showed an improved PFS and lengthened OS. Further studies in CR2 ovarian cancer patients are warranted (NCT01068509).\nTRIAL REGISTRATION: NCT01068509. Study Initiation Date (first patient screened): 20 July 2010. Study Completion Date (last patient observation): 20 August 2013, the last patient observation for progression-free survival; 29 April 2015, the last patient was documented regarding overall survival.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s40425-016-0137-x", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2475889", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1049249", 
        "issn": [
          "2051-1426"
        ], 
        "name": "Journal for ImmunoTherapy of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "name": "Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial", 
    "pagination": "34", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "9e11f68fab3ce7c34f24b16f4cc36500c817ea24d3db7e990152e8b0e0bdfd8a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "27330807"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101620585"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40425-016-0137-x"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1033181369"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40425-016-0137-x", 
      "https://app.dimensions.ai/details/publication/pub.1033181369"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T12:38", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000363_0000000363/records_70040_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs40425-016-0137-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40425-016-0137-x'


 

This table displays all metadata directly associated to this object as RDF triples.

291 TRIPLES      21 PREDICATES      50 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40425-016-0137-x schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Ne3c048d69bae4d489a0354183e34a6cf
4 schema:citation sg:pub.10.1007/s00018-015-2014-z
5 sg:pub.10.1186/2051-1426-1-s1-p213
6 sg:pub.10.1186/2051-1426-2-16
7 https://doi.org/10.1016/j.ejca.2008.10.026
8 https://doi.org/10.1016/j.jcyt.2013.01.184
9 https://doi.org/10.1016/j.ygyno.2007.02.004
10 https://doi.org/10.1021/jm5018237
11 https://doi.org/10.1056/nejmoa1103799
12 https://doi.org/10.1056/nejmoa1104390
13 https://doi.org/10.1056/nejmoa1504627
14 https://doi.org/10.1056/nejmoa1507643
15 https://doi.org/10.1056/nejmoa1510665
16 https://doi.org/10.1093/jnci/92.18.1534
17 https://doi.org/10.1158/1078-0432.ccr-05-1574
18 https://doi.org/10.1200/jco.2006.09.4540
19 https://doi.org/10.1200/jco.2014.55.7348
20 https://doi.org/10.1309/9r6673qec06d86y4
21 https://doi.org/10.1517/14712598.2015.1088519
22 https://doi.org/10.1615/critrevimmunol.v14.i3-4.40
23 https://doi.org/10.2217/fon.14.313
24 https://doi.org/10.2217/imt.10.17
25 schema:datePublished 2016-12
26 schema:datePublishedReg 2016-12-01
27 schema:description BACKGROUND: CAN-003 was a randomized, open-label, Phase 2 trial evaluating the safety, efficacy and immune outcomes of CVac, a mucin 1 targeted-dendritic cell (DC) treatment as a maintenance therapy to patients with epithelial ovarian cancer (EOC). METHODS: Patients (n = 56) in first (CR1) or second clinical remission (CR2) were randomized (1:1) to standard of care (SOC) observation or CVac maintenance treatment. Ten doses were administered over 56 weeks. Both groups were followed for progression-free survival (PFS) and overall survival (OS). RESULTS: Fifty-six patients were randomized: 27 to SOC and 29 to CVac. Therapy was safe with only seven patients with Grade 3-4 treatment-emergent adverse events. A variable but measurable mucin 1 T cell-specific response was induced in all CVac-treated and some standard of care (SOC) patients. Progression free survival (PFS) was not significantly longer in the treated group compared to SOC group (13 vs. 9 months, p = 0.36, hazard ratio [HR] = 0.73). Analysis by remission status showed in the CR1 subgroup a median PFS of 18 months (SOC) vs. 13 months (CVac); p = 0.69 (HR = 1.18; CI 0.52-2.71). However CR2 patients showed a longer median PFS in the CVac-treated group (median PFS not yet reached, >13 vs. 5 months; p = 0.04, HR = 0.32 CI). OS for CR2 patients at 42 months of follow-up showed a difference of 26 months for SOC vs. > 42 months for CVac-treated (as median OS had not been reached; HR = 0.17 (CI 0.02-1.4) with a p = 0.07). CONCLUSIONS: CVac, a mucin 1-dendritic cell maintenance treatment was safe and well tolerated in ovarian cancer patients. A variable but observed CVac-derived, mucin 1-specific T cell response was measured. Notably, CR2 patients showed an improved PFS and lengthened OS. Further studies in CR2 ovarian cancer patients are warranted (NCT01068509). TRIAL REGISTRATION: NCT01068509. Study Initiation Date (first patient screened): 20 July 2010. Study Completion Date (last patient observation): 20 August 2013, the last patient observation for progression-free survival; 29 April 2015, the last patient was documented regarding overall survival.
28 schema:genre research_article
29 schema:inLanguage en
30 schema:isAccessibleForFree true
31 schema:isPartOf N6e7da6e8c47b433b8e36eaafcdc62346
32 N803268e0b7fc4127a0b4009835caac4f
33 sg:journal.1049249
34 schema:name Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial
35 schema:pagination 34
36 schema:productId N04e251c8d73b497091dc22054cc83b2c
37 N179f1fb28f4548c985224ec09dbff250
38 N2d8d082faa1041b586d3f08bff0c7151
39 N9b43c8e2271141548a48b34a79d0de85
40 Neea5f781cf324fcda16962e020f18170
41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033181369
42 https://doi.org/10.1186/s40425-016-0137-x
43 schema:sdDatePublished 2019-04-11T12:38
44 schema:sdLicense https://scigraph.springernature.com/explorer/license/
45 schema:sdPublisher Nbc0ce0c1ffe541dcb4d03a66858d968c
46 schema:url https://link.springer.com/10.1186%2Fs40425-016-0137-x
47 sgo:license sg:explorer/license/
48 sgo:sdDataset articles
49 rdf:type schema:ScholarlyArticle
50 N01007f61e5d649f5a7300e3ccd709ef0 schema:name South Florida Center for Gynecologic Oncology, Boca Raton, FL, USA
51 rdf:type schema:Organization
52 N03fd90ecbf784fdcaa097b28a845ae74 rdf:first sg:person.014201702441.54
53 rdf:rest N4e1de8644cfe489b9a71d87043c2b583
54 N04e251c8d73b497091dc22054cc83b2c schema:name nlm_unique_id
55 schema:value 101620585
56 rdf:type schema:PropertyValue
57 N0b099d16dbe040f88d4acf15faa6c3a4 schema:name Prima BioMed, Sydney, NSW, Australia
58 rdf:type schema:Organization
59 N174b1fb4fb2443d3a6c842d66f6fcf1b rdf:first sg:person.01301461705.19
60 rdf:rest N7b7bc17ba8e04d2db9139b7a8597caa7
61 N179f1fb28f4548c985224ec09dbff250 schema:name pubmed_id
62 schema:value 27330807
63 rdf:type schema:PropertyValue
64 N19404907d8d644f4a895270e77282eba rdf:first sg:person.01306256505.25
65 rdf:rest N7ad18d1ebf7548a9a1fc3e03fdac06be
66 N22934c9048fe4844919348e2ff96aeb4 rdf:first sg:person.012011361041.38
67 rdf:rest N19404907d8d644f4a895270e77282eba
68 N2d8d082faa1041b586d3f08bff0c7151 schema:name readcube_id
69 schema:value 9e11f68fab3ce7c34f24b16f4cc36500c817ea24d3db7e990152e8b0e0bdfd8a
70 rdf:type schema:PropertyValue
71 N381e4a486ed74ed98ba5218c7933f9c2 rdf:first sg:person.013072753512.00
72 rdf:rest N50f587f5f13f4197af62106e4dc11aa6
73 N435fb93655ae44e7b2dfdba9e091ad34 schema:name Stanford Women’s Cancer Center, Stanford, CA, USA
74 rdf:type schema:Organization
75 N4e1de8644cfe489b9a71d87043c2b583 rdf:first sg:person.0766200410.40
76 rdf:rest N5d16341f46e8424bab84690b3033b6fd
77 N50f587f5f13f4197af62106e4dc11aa6 rdf:first sg:person.011262113641.15
78 rdf:rest Ne7efc58f6c034abb8c1e8ef7d55e3578
79 N5d16341f46e8424bab84690b3033b6fd rdf:first sg:person.01240016453.32
80 rdf:rest Nee905c74a801417fac6ffffdfcfe91c5
81 N69ad83cfed6c449d98cfaff1a09b4c17 rdf:first sg:person.014767761117.36
82 rdf:rest N22934c9048fe4844919348e2ff96aeb4
83 N6e7da6e8c47b433b8e36eaafcdc62346 schema:volumeNumber 4
84 rdf:type schema:PublicationVolume
85 N7ad18d1ebf7548a9a1fc3e03fdac06be rdf:first sg:person.01240411533.17
86 rdf:rest N03fd90ecbf784fdcaa097b28a845ae74
87 N7b7bc17ba8e04d2db9139b7a8597caa7 rdf:first sg:person.010516421017.70
88 rdf:rest N69ad83cfed6c449d98cfaff1a09b4c17
89 N803268e0b7fc4127a0b4009835caac4f schema:issueNumber 1
90 rdf:type schema:PublicationIssue
91 N9b43c8e2271141548a48b34a79d0de85 schema:name doi
92 schema:value 10.1186/s40425-016-0137-x
93 rdf:type schema:PropertyValue
94 Naee75bc649f949d9bca786cd0c9eb545 rdf:first sg:person.013452435241.07
95 rdf:rest rdf:nil
96 Nb62991d3fb93460ebd90c0ec100d5362 rdf:first sg:person.01116001617.09
97 rdf:rest Naee75bc649f949d9bca786cd0c9eb545
98 Nbc0ce0c1ffe541dcb4d03a66858d968c schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 Nbdc9df7023b248edadba665402e26fdd schema:name Marin Cancer Care, Greenbrae, CA, USA
101 rdf:type schema:Organization
102 Ndbb1f0897b694721a07d7082b4c7759d schema:name Greenslopes Private Hospital, Royal Brisbane & Women’s Hospital, University of Queensland & Gallipoli Research Foundation, Greenslopes, QLD, Australia
103 rdf:type schema:Organization
104 Nddd46875cba0428597d4f5da967288b2 rdf:first sg:person.01206754423.19
105 rdf:rest N381e4a486ed74ed98ba5218c7933f9c2
106 Ne3c048d69bae4d489a0354183e34a6cf rdf:first sg:person.0735642527.91
107 rdf:rest N174b1fb4fb2443d3a6c842d66f6fcf1b
108 Ne7efc58f6c034abb8c1e8ef7d55e3578 rdf:first sg:person.01144535603.40
109 rdf:rest Nb62991d3fb93460ebd90c0ec100d5362
110 Nee905c74a801417fac6ffffdfcfe91c5 rdf:first sg:person.01153251200.71
111 rdf:rest Nddd46875cba0428597d4f5da967288b2
112 Neea5f781cf324fcda16962e020f18170 schema:name dimensions_id
113 schema:value pub.1033181369
114 rdf:type schema:PropertyValue
115 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
116 schema:name Medical and Health Sciences
117 rdf:type schema:DefinedTerm
118 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
119 schema:name Oncology and Carcinogenesis
120 rdf:type schema:DefinedTerm
121 sg:grant.2475889 http://pending.schema.org/fundedItem sg:pub.10.1186/s40425-016-0137-x
122 rdf:type schema:MonetaryGrant
123 sg:journal.1049249 schema:issn 2051-1426
124 schema:name Journal for ImmunoTherapy of Cancer
125 rdf:type schema:Periodical
126 sg:person.010516421017.70 schema:affiliation N435fb93655ae44e7b2dfdba9e091ad34
127 schema:familyName Berek
128 schema:givenName J.
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010516421017.70
130 rdf:type schema:Person
131 sg:person.01116001617.09 schema:affiliation N0b099d16dbe040f88d4acf15faa6c3a4
132 schema:familyName Gargosky
133 schema:givenName S. E.
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116001617.09
135 rdf:type schema:Person
136 sg:person.011262113641.15 schema:affiliation https://www.grid.ac/institutes/grid.259828.c
137 schema:familyName Young
138 schema:givenName J.
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011262113641.15
140 rdf:type schema:Person
141 sg:person.01144535603.40 schema:affiliation https://www.grid.ac/institutes/grid.168010.e
142 schema:familyName Kohrt
143 schema:givenName H.
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01144535603.40
145 rdf:type schema:Person
146 sg:person.01153251200.71 schema:affiliation https://www.grid.ac/institutes/grid.26009.3d
147 schema:familyName Secord
148 schema:givenName A. Alvarez
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01153251200.71
150 rdf:type schema:Person
151 sg:person.012011361041.38 schema:affiliation https://www.grid.ac/institutes/grid.419722.b
152 schema:familyName Mason
153 schema:givenName J.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012011361041.38
155 rdf:type schema:Person
156 sg:person.01206754423.19 schema:affiliation https://www.grid.ac/institutes/grid.416113.0
157 schema:familyName Tchabo
158 schema:givenName N E.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01206754423.19
160 rdf:type schema:Person
161 sg:person.01240016453.32 schema:affiliation https://www.grid.ac/institutes/grid.239578.2
162 schema:familyName Michener
163 schema:givenName C. M.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240016453.32
165 rdf:type schema:Person
166 sg:person.01240411533.17 schema:affiliation https://www.grid.ac/institutes/grid.410678.c
167 schema:familyName Mitchell
168 schema:givenName P.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240411533.17
170 rdf:type schema:Person
171 sg:person.01301461705.19 schema:affiliation https://www.grid.ac/institutes/grid.416555.6
172 schema:familyName Benigno
173 schema:givenName B.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301461705.19
175 rdf:type schema:Person
176 sg:person.01306256505.25 schema:affiliation https://www.grid.ac/institutes/grid.1055.1
177 schema:familyName Mileshkin
178 schema:givenName L.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306256505.25
180 rdf:type schema:Person
181 sg:person.013072753512.00 schema:affiliation https://www.grid.ac/institutes/grid.266102.1
182 schema:familyName Chan
183 schema:givenName J. K.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013072753512.00
185 rdf:type schema:Person
186 sg:person.013452435241.07 schema:affiliation Ndbb1f0897b694721a07d7082b4c7759d
187 schema:familyName Goh
188 schema:givenName J. C.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013452435241.07
190 rdf:type schema:Person
191 sg:person.014201702441.54 schema:affiliation https://www.grid.ac/institutes/grid.416112.1
192 schema:familyName Moradi
193 schema:givenName M.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014201702441.54
195 rdf:type schema:Person
196 sg:person.014767761117.36 schema:affiliation Nbdc9df7023b248edadba665402e26fdd
197 schema:familyName Chang
198 schema:givenName J.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014767761117.36
200 rdf:type schema:Person
201 sg:person.0735642527.91 schema:affiliation https://www.grid.ac/institutes/grid.412623.0
202 schema:familyName Gray
203 schema:givenName H. J.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735642527.91
205 rdf:type schema:Person
206 sg:person.0766200410.40 schema:affiliation N01007f61e5d649f5a7300e3ccd709ef0
207 schema:familyName Recio
208 schema:givenName F. O.
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0766200410.40
210 rdf:type schema:Person
211 sg:pub.10.1007/s00018-015-2014-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1053537243
212 https://doi.org/10.1007/s00018-015-2014-z
213 rdf:type schema:CreativeWork
214 sg:pub.10.1186/2051-1426-1-s1-p213 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018712024
215 https://doi.org/10.1186/2051-1426-1-s1-p213
216 rdf:type schema:CreativeWork
217 sg:pub.10.1186/2051-1426-2-16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007070580
218 https://doi.org/10.1186/2051-1426-2-16
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/j.ejca.2008.10.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026558254
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/j.jcyt.2013.01.184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014256254
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1016/j.ygyno.2007.02.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009417955
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1021/jm5018237 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010331914
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1056/nejmoa1103799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052109861
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1056/nejmoa1104390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035779003
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1056/nejmoa1504627 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052572745
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1056/nejmoa1507643 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000663586
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1056/nejmoa1510665 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019970557
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1093/jnci/92.18.1534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038214940
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1158/1078-0432.ccr-05-1574 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009558049
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1200/jco.2006.09.4540 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020656211
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1200/jco.2014.55.7348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051247162
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1309/9r6673qec06d86y4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021159180
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1517/14712598.2015.1088519 schema:sameAs https://app.dimensions.ai/details/publication/pub.1067589143
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1615/critrevimmunol.v14.i3-4.40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068131598
251 rdf:type schema:CreativeWork
252 https://doi.org/10.2217/fon.14.313 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038967503
253 rdf:type schema:CreativeWork
254 https://doi.org/10.2217/imt.10.17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032207164
255 rdf:type schema:CreativeWork
256 https://www.grid.ac/institutes/grid.1055.1 schema:alternateName Peter MacCallum Cancer Centre
257 schema:name Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia
258 rdf:type schema:Organization
259 https://www.grid.ac/institutes/grid.168010.e schema:alternateName Stanford University
260 schema:name Stanford University Cancer Institute, Stanford, CA, USA
261 rdf:type schema:Organization
262 https://www.grid.ac/institutes/grid.239578.2 schema:alternateName Cleveland Clinic
263 schema:name Cleveland Clinic Foundation, Cleveland, OH, USA
264 rdf:type schema:Organization
265 https://www.grid.ac/institutes/grid.259828.c schema:alternateName Medical University of South Carolina
266 schema:name Medical University of South Carolina, Charleston, SC, USA
267 rdf:type schema:Organization
268 https://www.grid.ac/institutes/grid.26009.3d schema:alternateName Duke University
269 schema:name Duke Cancer Institute, Duke University Health System, Durham, NC, USA
270 rdf:type schema:Organization
271 https://www.grid.ac/institutes/grid.266102.1 schema:alternateName University of California, San Francisco
272 schema:name University of California, San Francisco & Sutter Health Research Institute, San Francisco, CA, USA
273 rdf:type schema:Organization
274 https://www.grid.ac/institutes/grid.410678.c schema:alternateName Austin Health
275 schema:name Olivia Newton-John Cancer and Wellness Centre, Austin Health, Heidelberg, Vic, Australia
276 rdf:type schema:Organization
277 https://www.grid.ac/institutes/grid.412623.0 schema:alternateName University of Washington Medical Center
278 schema:name University of Washington Medical Center, Seattle, WA, USA
279 rdf:type schema:Organization
280 https://www.grid.ac/institutes/grid.416112.1 schema:alternateName Lower Manhattan Hospital
281 schema:name New York Downtown Hospital, New York, NY, USA
282 rdf:type schema:Organization
283 https://www.grid.ac/institutes/grid.416113.0 schema:alternateName Morristown Medical Center
284 schema:name Morristown Medical Center, Morristown, NJ, USA
285 rdf:type schema:Organization
286 https://www.grid.ac/institutes/grid.416555.6 schema:alternateName Northside Hospital
287 schema:name Northside Hospital, Atlanta, GA, USA
288 rdf:type schema:Organization
289 https://www.grid.ac/institutes/grid.419722.b schema:alternateName Scripps Health
290 schema:name Scripps Cancer Center, San Diego, CA, USA
291 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...